Table of Contents Author Guidelines Submit a Manuscript
Journal of Skin Cancer
Volume 2011, Article ID 845863, 6 pages
http://dx.doi.org/10.1155/2011/845863
Review Article

Management of Melanoma Brain Metastases in the Era of Targeted Therapy

1Section of Melanoma, Renal Cancer and Immunotherapy, Nevada Cancer Institute, One Breakthrough Way, Las Vegas, NV 89135, USA
2Comprehensive Cancer Centers of Nevada, Henderson, NV 89014, USA
3US Oncology Research Developmental Therapeutics and Genitourinary Committees, Woodloch, TX, USA
4University of Nevada, Reno, NV, USA

Received 16 February 2011; Accepted 7 November 2011

Academic Editor: John M. Kirkwood

Copyright © 2011 Daniela Gonsalves Shapiro and Wolfram E. Samlowski. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [11 citations]

The following is the list of published articles that have cited the current article.

  • Rosalie Fisher, and James Larkin, “Treatment of brain metastases in patients with melanoma,” Lancet Oncology, vol. 13, no. 5, pp. 434–435, 2012. View at Publisher · View at Google Scholar
  • Riccardo Soffietti, Elisa Trevisan, and Roberta Rudà, “Targeted therapy in brain metastasis,” Current Opinion in Oncology, vol. 24, no. 6, pp. 679–686, 2012. View at Publisher · View at Google Scholar
  • Elizabeth Harford-Wright, Kate M. Lewis, Robert Vink, and Mounir N. Ghabriel, “Evaluating the Role of Substance P in the Growth of Brain Tumors,” Neuroscience, 2013. View at Publisher · View at Google Scholar
  • Igor Puzanov, Jedd D Wolchok, Paolo A Ascierto, Omid Hamid, and Kim Margolin, “Anti-CTLA-4 and BRAF inhibition in patients with metastatic melanoma and brain metastases,” Expert Review of Dermatology, vol. 8, no. 5, pp. 479–487, 2013. View at Publisher · View at Google Scholar
  • J. Wang, Z. -Z. Guo, Y. -J. Wang, S. -G. Zhang, and D. -G. Xing, “Microsurgery for the treatment of primary malignant intracranial melanoma: A surgical series and literature review,” Ejso, vol. 40, no. 9, pp. 1062–1071, 2014. View at Publisher · View at Google Scholar
  • Francis Vekeman, Michel Cloutier, Sander Yermakov, Mayur M. Amonkar, Bhakti Arondekar, and Mei S. Duh, “Economic burden of brain metastases among patients with metastatic melanoma in a USA managed care population,” Melanoma Research, vol. 24, no. 6, pp. 602–610, 2014. View at Publisher · View at Google Scholar
  • Laxminadh Sivaraju, Saritha Aryan, Vinay S Hegde, Nandita Ghosal, and Alangar S Hegde, “Aggressive solitary intracranial metastatic malignant melanoma from a primary mediastinal tumour.,” The neuroradiology journal, vol. 29, no. 4, pp. 269–72, 2016. View at Publisher · View at Google Scholar
  • Dimitri Trembath, Carrie B. Lee, Timothy M. Zagar, Stergios J. Moschos, Frances A. Collichio, and Matthew G. Ewendvol. 3, pp. 237–254, 2016. View at Publisher · View at Google Scholar
  • Gautham Gampa, Shruthi Vaidhyanathan, Brynna Wilken-Resman, Karen E. Parrish, Svetomir N. Markovic, Jann N. Sarkaria, and William F. Elmquist, “Challenges in the Delivery of Therapies to Melanoma Brain Metastases,” Current Pharmacology Reports, 2016. View at Publisher · View at Google Scholar
  • John F. Thompson, Brindha Shivalingam, Angela M. Hong, Megan Lyle, and Georgina V. Long, “Brain Metastases from Melanoma,” Brain Metastases from Primary Tumors, Volume 3, pp. 65–83, 2016. View at Publisher · View at Google Scholar
  • Joonho Byun, Eun Suk Park, Seok Ho Hong, Young Hyun Cho, Young-Hoon Kim, Chang Jin Kim, Jeong Hoon Kim, and Seungjoo Lee, “Clinical outcomes of primary intracranial malignant melanoma and metastatic intracranial malignant melanoma,” Clinical Neurology and Neurosurgery, vol. 164, pp. 32–38, 2018. View at Publisher · View at Google Scholar